Bergner et al. Journal of Medical Case Reports 2011, 5:409 http://www.jmedicalcasereports.com/content/5/1/409 and supervised the writing of the case report. All authors were involved with the treatment of the patient, and all authors read and approved the final manuscript. Competing interests The authors declare that they have no competing interests. Received: 31 March 2011 Accepted: 24 August 2011 Published: 24 August 2011 References 1. Klopstock T: Drug induced myopathies. Curr Opin Neurol 2008, 21:590-595. 2. Buchbinder R, Forbes A, Hall S, Denett X, Giles G: Incidence of malignant disease in biopsy-proven inflammatory myopathy. Ann Intern Med 2001, 134:1087-1095. 3. Stockton D, Doherty VR, Brewster DH: Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001, 85:41-45. 4. Bannwarth B: Drug-induced myopathies. Expert Opin Drug Saf 2002, 1:65-70. 5. Bannwarth B: Drug-induced musculoskeletal disorders. Drug Saf 2007, 30:27-46. 6. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992, 326:363-367. 7. András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Dankó K: Dermatomyositis and polymyositis associated with malignancy: a 21- year retrospective study. J Rheumatol 2008, 35:438-444. 8. Targoff IN: Autoantibodies and their significance in myositis. Curr Rheumatol Rep 2008, 10:333-340. 9. Targoff IN: Myositis specific autoantibodies. Curr Rheumatol Rep 2006, 8:196-203. 10. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A: Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006, 39:217-221. 11. Levine SM: Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 2006, 18:620-624. 12. Crayton H, Bohlmann T, Sufit R, Graziano FM: Drug induced polymyositis secondary to leuprolide acetate (Lupron) therapy for prostate carcinoma. Clin Exp Rheumatol 1991, 9:525-528. 13. Van Gerpen JA, McKinley KL: Leuprolide-induced myopathy. J Am Geriatr Soc 2002, 50:1746-1747. 14. Salvador Hernández J, Ferrera Rodríguez R, Martín Oliva MV: LH-RH analogues and myopathy in Spanish. Aten Primaria 2004, 34:265. doi:10.1186/1752-1947-5-409 Cite this article as: Bergner et al.: Inflammatory myopathy and severe rhabdomyolysis induced by leuprolide acetate therapy for prostate cancer: a case report. Journal of Medical Case Reports 2011 5:409. Page 4 of 4 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit